<p>(A) Dialysate/plasma (D/P) ratio of urea nitrogen (UN); (B) peritoneal absorption of glucose from dialysate (D/D0) in control mice, MGO-injected mice treated with vehicle only, and MGO-injected mice treated with sinefungin during 10-min dialysate dwell (4.25% dialysis solution). Data are means ± S.D. *, <i>P</i> < 0.05 (one-way ANOVA followed by <i>post hoc</i> test using <i>t</i> test with Bonferroni correction; <i>n</i> = 5 mice per group).</p
The development of peritoneal dialysis (PD) as a successful therapy has and still depends on experim...
Background: Long-term exposure of conventional peritoneal dialysis (PD) fluid is associated with str...
Chronic inflammatory conditions during peritoneal dialysis (PD)-treatment lead to the impairment of ...
<p>(A) Typical H3K4me1 levels in peritoneal tissue of control mice, MGO-injected mice treated with v...
<p>(A) Typical hematoxylin-eosin staining of peritoneal tissues of control mice, MGO-injected mice t...
<p>(A) Typical type I collagen expression in peritoneal tissue of control mice, MGO-injected mice tr...
<div><p>Transforming growth factor-β1 (TGF-β1) is a major mediator of peritoneal fibrosis and report...
Transforming growth factor-β1 (TGF-β1) is a major mediator of peritoneal fibrosis and reportedly aff...
Different animal models for peritoneal dialysis (PD) have been used in the past decades to develop P...
Recent studies have reported increases of methylglyoxal (MGO) in peritoneal dialysis patients, and t...
BACKGROUND: Animal models are important for understanding the physiology and pathophysiology of peri...
Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse.Backg...
Copyright © 2015 E. Ferrantelli et al. This is an open access article distributed under the Creative...
The development of peritoneal dialysis has been paralleled by a growing interest in establishing sui...
Pharmacologic studies suggest that the release of nitric oxide (NO) by endothelial NO synthase (eNOS...
The development of peritoneal dialysis (PD) as a successful therapy has and still depends on experim...
Background: Long-term exposure of conventional peritoneal dialysis (PD) fluid is associated with str...
Chronic inflammatory conditions during peritoneal dialysis (PD)-treatment lead to the impairment of ...
<p>(A) Typical H3K4me1 levels in peritoneal tissue of control mice, MGO-injected mice treated with v...
<p>(A) Typical hematoxylin-eosin staining of peritoneal tissues of control mice, MGO-injected mice t...
<p>(A) Typical type I collagen expression in peritoneal tissue of control mice, MGO-injected mice tr...
<div><p>Transforming growth factor-β1 (TGF-β1) is a major mediator of peritoneal fibrosis and report...
Transforming growth factor-β1 (TGF-β1) is a major mediator of peritoneal fibrosis and reportedly aff...
Different animal models for peritoneal dialysis (PD) have been used in the past decades to develop P...
Recent studies have reported increases of methylglyoxal (MGO) in peritoneal dialysis patients, and t...
BACKGROUND: Animal models are important for understanding the physiology and pathophysiology of peri...
Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse.Backg...
Copyright © 2015 E. Ferrantelli et al. This is an open access article distributed under the Creative...
The development of peritoneal dialysis has been paralleled by a growing interest in establishing sui...
Pharmacologic studies suggest that the release of nitric oxide (NO) by endothelial NO synthase (eNOS...
The development of peritoneal dialysis (PD) as a successful therapy has and still depends on experim...
Background: Long-term exposure of conventional peritoneal dialysis (PD) fluid is associated with str...
Chronic inflammatory conditions during peritoneal dialysis (PD)-treatment lead to the impairment of ...